TD Cowen analyst Joshua Jennings lowered the firm’s price target on Outset Medical (OM) to $15 from $25 and keeps a Buy rating on the shares. The firm lower its target to reflect slightly slower-than-expected progress in the ongoing turnaround.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on OM: